Atea Pharmaceuticals shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Atea Pharmaceuticals by Charles Schwab Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $2.2M | 650k | 3.35 |
2024-06-30 | $2.0M | 599k | 3.31 |
2024-03-31 | $2.5M | 612k | 4.04 |
2023-12-31 | $1.8M | 584k | 3.05 |
2023-09-30 | $1.7M | 582k | 3.00 |
2023-06-30 | $2.1M | 574k | 3.74 |
2023-03-31 | $1.8M | 526k | 3.35 |
2022-12-31 | $2.7M | 565k | 4.81 |
2022-09-30 | $3.1M | 553k | 5.69 |
2022-06-30 | $3.0M | 428k | 7.10 |
2022-03-31 | $3.0M | 415k | 7.22 |
2021-12-31 | $3.5M | 395k | 8.94 |
2021-09-30 | $14M | 393k | 35.06 |
2021-06-30 | $4.2M | 196k | 21.48 |
2021-03-31 | $5.5M | 89k | 61.75 |
2020-12-31 | $3.6M | 86k | 41.79 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management